2008 PRESS RELEASE ARCHIVE
November 11, 2008 - GTC Biotherapeutics Receives NASDAQ Notice
November 5, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference
November 3, 2008 - GTC Biotherapeutics Reports Third Quarter 2008 Financial Results
November 3, 2008 - GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB - Financing Subject to Shareholder Approval
October 29, 2008 - GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008
October 6, 2008 - FDA Accepts ATrynŽ BLA Filing - GTC Receives $2 Million in Additional Milestone Payments
September 4, 2008 - FDA Assigns Priority Review to GTC BiotherapeuticsATrynŽ
August 14, 2008 - GTC Biotherapeutics and Ovation Pharmaceuticals Close Agreement to Market and Develop ATrynŽ in the U.S.
August 7, 2008 - GTC Biotherapeutics Completes BLA Submission for AtrynŽ
August 7, 2008 - GTC Biotherapeutics Reports Second Quarter 2008 Financial Results
July 31, 2008 - GTC Biotherapeutics to Announce Second Quarter 2008 Earnings on Thursday, August 7th, 2008
July 25, 2008 - GTC Biotherapeutics to Transfer to NASDAQ Capital Market
July 18, 2008 - GTC Biotherapeutics Receives NASDAQ Notice of Non-Compliance
July 7, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the Collins Stewart Fourth Annual Growth Conference
July 2, 2008 - GTC Biotherapeutics Receives Notice Related to NASDAQ Minimum Market Value Rule
June 25, 2008 - GTC Biotherapeutics Licenses Recombinant Fibrinogen Patents to Pharming
June 23, 2008 - GTC Biotherapeutics Enters into $257 Million Agreement with OVATION Pharmaceuticals to Develop and Market ATrynŽ in the U.S.
May 13, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
May 8, 2008 - GTC Biotherapeutics Reports First Quarter 2008 Financial Results
May 8, 2008 - LFB Biotechnologies and GTC Biotherapeutics to Collaborate on rhAAT Program
March 27, 2008 - GTC Biotherapeutics and Pharmathene Extend Agreement for ProtexiaŽ Program
March 6, 2008 - GTC Biotherapeutics Reports Fourth Quarter and Year End 2007 Financial Results
February 28, 2008 - GTC Biotherapeutics to Host Fourth Quarter and Year End 2007 Earnings Call and Webcast on Thursday, March 6, 2008
February 25, 2008 - Last Patient Enrolled in ATrynŽ Pivotal Study
February 8, 2008 - GTC Biotherapeutics to Raise $6 Million in Registered Direct Offering
February 6, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the 10th Annual BIO CEO & Investor Conference
February 4, 2008 - ATrynŽ Meets Primary Endpoint/Rolling BLA Submission Initiated
January 18, 2008 - GTC Biotherapeutics Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule
January 10, 2008 - LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
January 7, 2008 - ATrynŽ Nears Completion of US HD Clinical Study